Soy for Breast Cancer Survivors: A Critical Review of the Literature

United Soybean Board (2000) 7th Annual Consumer Attitudes about Nutrition, 2000–2001 National Report. United Soybean Board, St. Louis, MO. Based soy food maker stays a nose above the competition. Industry News. http://www.soyatech.com. Accessed July 20, 2001. Adlercreutz, 1997, Phyto-oestrogens and Western diseases, Ann. Med, 29, 95, 10.3109/07853899709113696 Fournier, 1998, Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data, Cancer Epidemiol. Biomark. Prev, 7, 1055 Messina, 1994, Soy intake and cancer risk: a review of the in vitro and in vivo data, Nutr. Cancer, 21, 113, 10.1080/01635589409514310 Messina, M., Gugger, E. T. & Alekel, D. L. (2001) Soy protein, soybean isoflavones, and bone health: a review of the animal and human data. In: Handbook of Nutraceuticals and Functional Foods (Wildman, R., ed.), pp. 77–98. CRC Press, Boca Raton, FL. Anderson, 1998, Phytoestrogens and bone, Baillieres Clin. Endocrinol. Metab, 12, 543, 10.1016/S0950-351X(98)80003-7 Erdman, 2000, Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA, Circulation, 102, 2555, 10.1161/01.CIR.102.20.2555 1999, Food labeling, health claims, soy protein, and coronary heart disease, Fed. Regist, 57, 699 Messina, 1991, The role of soy products in reducing risk of cancer, J. Natl. Cancer Inst, 83, 541, 10.1093/jnci/83.8.541 Franke, 1998, HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids, Proc. Soc. Exp. Biol. Med, 217, 263, 10.3181/00379727-217-44231 Liggins, 2000, Daidzein and genistein content of fruits and nuts, J. Nutr. Biochem, 11, 326, 10.1016/S0955-2863(00)00085-1 Liggins, 2000, Daidzein and genistein contents of vegetables, Br. J. Nutr, 84, 717, 10.1017/S0007114500002075 Murphy, 1999, Isoflavones in retail and institutional soy foods, J. Agric. Food Chem, 47, 2697, 10.1021/jf981144o Lu, 2001, Phytoestrogens and healthy aging: gaps in knowledge. A workshop report, Menopause, 8, 157, 10.1097/00042192-200105000-00004 Osborne, 2000, Selective estrogen receptor modulators: structure, function, and clinical use, J. Clin. Oncol, 18, 3172, 10.1200/JCO.2000.18.17.3172 Brzezinski, 1999, Phytoestrogens: the “natural” selective estrogen receptor modulators?, Eur. J. Obstet. Gynecol. Reprod. Biol, 85, 47, 10.1016/S0301-2115(98)00281-4 An, 2001, Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens, J. Biol. Chem, 276, 17808, 10.1074/jbc.M100953200 Akiyama, 1991, Use and specificity of genistein as inhibitor of protein-tyrosine kinases, Methods Enzymol, 201, 362, 10.1016/0076-6879(91)01032-W Constantinou, 1995, Genistein as an inducer of tumor cell differentiation: possible mechanisms of action, Proc. Soc. Exp. Biol. Med, 208, 109, 10.3181/00379727-208-43841 Kim, 1998, Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways, Am. J. Clin. Nutr, 68, 1418S, 10.1093/ajcn/68.6.1418S Garton, 1995, The climacteric, osteoporosis and hormone replacement; views of women aged 45–49, Maturitas, 21, 7, 10.1016/0378-5122(94)00864-4 Vihtamaki, 1999, Why do postmenopausal women discontinue hormone replacement therapy?, Maturitas, 33, 99, 10.1016/S0378-5122(99)00047-X MacLennan, 2001, Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review, Climacteric, 4, 58, 10.1080/cmt.4.1.58.74 Brett, 1997, Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study, Am. J. Epidemiol, 145, 536, 10.1093/oxfordjournals.aje.a009142 Keating, 1999, Use of hormone replacement therapy by postmenopausal women in the United States, Ann. Intern. Med, 130, 545, 10.7326/0003-4819-130-7-199904060-00002 Heckbert, 1997, Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women, Arch. Intern. Med, 157, 1330, 10.1001/archinte.1997.00440330066007 Schneider, 1997, Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study, J. Am. Med. Assoc, 277, 543, 10.1001/jama.1997.03540310041032 Grady, 2000, Hormones to prevent coronary disease in women: when are observational studies adequate evidence?, Ann. Intern. Med, 133, 999, 10.7326/0003-4819-133-12-200012190-00016 van der Schouw, 2001, HRT and heart disease: Dr Jekyll or Mrs Hyde?, Maturitas, 38, 213, 10.1016/S0378-5122(01)00176-1 Cauley, 2001, Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS), Am. J. Med, 110, 442, 10.1016/S0002-9343(01)00647-7 Grady, 2001, Postmenopausal hormone therapy for prevention of fractures. How good is the evidence?, J. Am. Med. Assoc, 285, 2909, 10.1001/jama.285.22.2909 Lee, 2000, Alternative therapies used by women with breast cancer in four ethnic populations, J. Natl. Cancer Inst, 92, 42, 10.1093/jnci/92.1.42 Morris, 2000, A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites, Am. J. Surg, 179, 407, 10.1016/S0002-9610(00)00358-5 Couzi, 1995, Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy, J. Clin. Oncol, 13, 2737, 10.1200/JCO.1995.13.11.2737 Carpenter, 1998, Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life, Cancer, 82, 1682, 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0 Col, 2001, Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk, J. Clin. Oncol, 19, 2357, 10.1200/JCO.2001.19.8.2357 Bouker, 2000, Genistein: does it prevent or promote breast cancer?, Environ. Health Perspect, 108, 701, 10.1289/ehp.00108701 2001, Nutrition during and after cancer treatment: a guide for informed choices by cancer survivors, CA-Cancer J. Clin, 51, 153, 10.3322/canjclin.51.3.153 Affenito, 1999, Position of the American Dietetic Association and Dietitians of Canada: women's health and nutrition, J. Am. Diet. Assoc, 99, 738, 10.1016/S0002-8223(99)00178-9 2001, Use of botanicals for management of menopausal symptoms, ACOG Pract. Bull, 28, 1 Barnes, 1990, Soybeans inhibit mammary tumors in models of breast cancer, Prog. Clin. Biol. Res, 347, 239 Howe, 1992, High-fat diets and breast cancer risk. The epidemiologic evidence, J. Am. Med. Assoc, 268, 2080, 10.1001/jama.1992.03490150132039 Howe, 1990, Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies, J. Natl. Cancer Inst, 82, 561, 10.1093/jnci/82.7.561 Prentice, 2000, Future possibilities in the prevention of breast cancer: fat and fiber and breast cancer research, Breast Cancer Res, 2, 268, 10.1186/bcr68 Wu, 1999, Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer, J. Natl. Cancer Inst, 91, 529, 10.1093/jnci/91.6.529 Holmes, 1999, Association of dietary intake of fat and fatty acids with risk of breast cancer [see comments], J. Am. Med. Assoc, 281, 914, 10.1001/jama.281.10.914 Holmes, 1999, Re: Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer, J. Natl. Cancer Inst, 91, 1511, 10.1093/jnci/91.17.1511 Cohen, 1999, Dietary fiber and breast cancer, Anticancer Res, 19, 3685 Smith-Warner, 2001, Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies, J. Am. Med. Assoc, 285, 769, 10.1001/jama.285.6.769 Lee, 1991, Dietary effects on breast-cancer risk in Singapore, Lancet, 337, 1197, 10.1016/0140-6736(91)92867-2 Folman, 1966, The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency, J. Endocrinol, 34, 215, 10.1677/joe.0.0340215 Ogawara, 1986, A specific inhibitor for tyrosine protein kinase from pseudomonas, J. Antibiot. (Tokyo), 39, 606, 10.7164/antibiotics.39.606 Akiyama, 1987, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J. Biol. Chem, 262, 5592, 10.1016/S0021-9258(18)45614-1 Hunter, 1985, Protein-tyrosine kinases, Annu. Rev. Biochem, 54, 897, 10.1146/annurev.bi.54.070185.004341 Constantinou, 1990, Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein, Cancer Res, 50, 2618 Wang, 1994, Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location, J. Agric. Food Chem, 42, 1674, 10.1021/jf00044a017 Carrão-Panizzi, 1995, Isoflavone content in Brazilian soybean cultivars, Breeding Sci, 45, 295 Nakamura, 2000, Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake, J. Assoc. Off. Anal. Chem. Int, 83, 635 Somekawa, 2001, Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women, Obstet. Gynecol, 97, 109 Nagata, 1998, Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women, J. Nutr, 128, 209, 10.1093/jn/128.2.209 Wakai, 1999, Dietary intake and sources of isoflavones among Japanese, Nutr. Cancer, 33, 139, 10.1207/S15327914NC330204 Santell, 2000, Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice, J. Nutr, 130, 1665, 10.1093/jn/130.7.1665 Xu, 1995, Bioavailability of soybean isoflavones depends upon gut microflora in women, J. Nutr, 125, 2307, 10.1093/jn/125.9.2307 Xu, 1994, Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women, J. Nutr, 124, 825, 10.1093/jn/124.6.825 Watanabe, 1998, Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako), J. Nutr, 128, 1710, 10.1093/jn/128.10.1710 King, 1998, Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans, Am. J. Clin. Nutr, 67, 867, 10.1093/ajcn/67.5.867 Adlercreutz, 1993, Plasma concentrations of phyto-oestrogens in Japanese men, Lancet, 342, 1209, 10.1016/0140-6736(93)92188-Y Griffiths, 1998, Phytoestrogens and diseases of the prostate gland, Baillieres Clin. Endocrinol. Metab, 12, 625, 10.1016/S0950-351X(98)80008-6 Fanti, 1999, Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients, J. Am. Soc. Nephrol, 10, 864, 10.1681/ASN.V104864 Shelnutt, 2000, Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein, Cancer Epidemiol. Biomark. Prev, 9, 413 Setchell, 1998, Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones, Am. J. Clin. Nutr, 68, 1333S, 10.1093/ajcn/68.6.1333S Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J. Nutr, 131, 1362S, 10.1093/jn/131.4.1362S Markiewicz, 1993, In vitro bioassays of non-steroidal phytoestrogens, J. Steroid Biochem. Mol. Biol, 45, 399, 10.1016/0960-0760(93)90009-L Mayr, 1992, Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts, Toxicology, 74, 135, 10.1016/0300-483X(92)90134-Z Nagel, 1998, The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity, Proc. Soc. Exp. Biol. Med, 217, 300, 10.3181/00379727-217-44236 Walker, 2001, The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol, Circulation, 103, 258, 10.1161/01.CIR.103.2.258 Makela, 1999, Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta, Proc. Natl. Acad. Sci. U.S.A, 96, 7077, 10.1073/pnas.96.12.7077 Duncan, 1999, Soy isoflavones exert modest hormonal effects in premenopausal women, J. Clin. Endocrinol. Metab, 84, 192 Upmalis, 2000, Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study, Menopause, 7, 236, 10.1097/00042192-200007040-00005 Fanti, 1998, The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats, Osteoporos. Int, 8, 274, 10.1007/s001980050065 Ishida, 1998, Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet, Biol. Pharm. Bull, 21, 62, 10.1248/bpb.21.62 Probst-Hensch, 2000, Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight, Br. J. Cancer, 82, 1867, 10.1054/bjoc.1999.1082 Nestel, 1999, Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women [published erratum appears in J. Clin. Endocrinol. Metab. 84: 3647], J. Clin. Endocrinol. Metab, 84, 895 Nestel, 1997, Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women, Arterioscler. Thromb. Vasc. Biol, 17, 3392, 10.1161/01.ATV.17.12.3392 Davis, 2001, Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes, Free Radic. Biol. Med, 30, 1293, 10.1016/S0891-5849(01)00535-4 Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, 138, 863, 10.1210/endo.138.3.4979 Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, 139, 4252, 10.1210/endo.139.10.6216 Casanova, 1999, Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro, Toxicol. Sci, 51, 236, 10.1093/toxsci/51.2.236 Cassidy, 2000, Phyto-oestrogens through the life cycle, Proc. Nutr. Soc, 59, 489, 10.1017/S0029665100000719 Gustafsson, 1998, Therapeutic potential of selective estrogen receptor modulators, Curr. Opin. Chem. Biol, 2, 508, 10.1016/S1367-5931(98)80127-0 Pike, 1999, Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist, EMBO J, 18, 4608, 10.1093/emboj/18.17.4608 Singh, 2001, Development of QSAR models to predict estrogenic, carcinogenic, and cancer protective effects of phytoestrogens, Cancer Investig, 19, 201, 10.1081/CNV-100000155 Hunter, 1999, Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium, Cancer Res, 59, 3090 Dees, 1997, Dietary estrogens stimulate human breast cells to enter the cell cycle, Environ. Health Perspect, 105, 633 Makela, 1994, Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells, Environ. Health Perspect, 102, 572, 10.1289/ehp.94102572 Zava, 1997, Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro, Nutr. Cancer, 27, 31, 10.1080/01635589709514498 Miodini, 1999, The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function, Br. J. Cancer, 80, 1150, 10.1038/sj.bjc.6690479 Sathyamoorthy, 1997, Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells, Eur. J. Cancer, 33, 2384, 10.1016/S0959-8049(97)00303-1 Barkhem, 1998, Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists, Mol. Pharmacol, 54, 105, 10.1124/mol.54.1.105 Kao, 1998, Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study, Environ. Health Perspect, 106, 85, 10.1289/ehp.9810685 Adlercreutz, 1993, Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens, J. Steroid Biochem. Mol. Biol, 44, 147, 10.1016/0960-0760(93)90022-O Campbell, 1993, Flavonoid inhibition of aromatase enzyme activity in human preadipocytes, J. Steroid Biochem. Mol. Biol, 46, 381, 10.1016/0960-0760(93)90228-O Kirk, 2001, Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens?, Biochem. Soc. Trans, 29, 209, 10.1042/bst0290209 Makela, 1998, Inhibition of 17β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells, Proc. Soc. Exp. Biol. Med, 217, 310, 10.3181/00379727-217-44237 Le Bail, 2000, Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells, Life Sci, 66, 1281, 10.1016/S0024-3205(00)00435-5 Clemons, 2001, Estrogen and the risk of breast cancer, N. Engl. J. Med, 344, 276, 10.1056/NEJM200101253440407 Purohit, 1999, Regulation of steroid sulphatase and oestradiol 17 beta-hydroxysteroid dehydrogenase in breast cancer, Biochem. Soc. Trans, 27, 323, 10.1042/bst0270323 Foth, 1998, Effects of mammalian and plant estrogens on mammary glands and uteri of macaques, Am. J. Clin. Nutr, 68, 1413S, 10.1093/ajcn/68.6.1413S Weber, 1999, Regulation of signal transduction activity in normal and cancer cells, Anticancer Res, 19, 3703 Meng, 1999, Antiproliferative efficacy of lipophilic soy isoflavone phytoestrogens delivered by low density lipoprotein particles into cultured U937 cells, Life Sci, 65, 1695, 10.1016/S0024-3205(99)00418-X Ruiz-Larrea, 1997, Antioxidant activity of phytoestrogenic isoflavones, Free Radic. Res, 26, 63, 10.3109/10715769709097785 Peterson, 1991, Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene, Biochem. Biophys. Res. Commun, 179, 661, 10.1016/0006-291X(91)91423-A Pagliacci, 1994, Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells, Eur. J. Cancer, 11, 1675, 10.1016/0959-8049(94)00262-4 Peterson, 1996, Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells, Cell Growth Differ, 7, 1345 Hsieh, 1998, Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo, Cancer Res, 58, 3833 Shao, 2000, Genistein's “ER-dependent and independent” actions are mediated through ER pathways in ER-positive breast carcinoma cell lines, Anticancer Res, 20, 2409 Twaddle, 1999, Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro, J. Surg. Oncol, 70, 83, 10.1002/(SICI)1096-9098(199902)70:2<83::AID-JSO4>3.0.CO;2-L Li, 1999, Induction of apoptosis and inhibition of C-ERBB-2 in MDA-MB-435 cells by genistein, Int. J. Oncol, 15, 525 Shen, 1999, Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells, Anticancer Res, 19, 1657 Shao, 1998, Genistein exerts multiple suppressive effects on human breast carcinoma cells, Cancer Res, 58, 4851 Leung, 2000, Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration, J. Nutr, 130, 2922, 10.1093/jn/130.12.2922 Lin, 2000, Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis, Carcinogenesis, 21, 1941, 10.1093/carcin/21.11.1941 Fioravanti, 1998, Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro, Cancer Lett, 130, 143, 10.1016/S0304-3835(98)00130-X Martinez-Campos, 1986, Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures, Mol. Cell. Endocrinol, 48, 127, 10.1016/0303-7207(86)90035-3 Wang, 1998, Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors, Nutr. Cancer, 31, 90, 10.1080/01635589809514686 Scholar, 1994, Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein, Cancer Lett, 87, 159, 10.1016/0304-3835(94)90217-8 Santibanez, 1997, Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines, Anticancer Res, 17, 1199 Dalu, 1998, Genistein, a component of soy, inhibits the expression of the EGF and ERBB2/NEU receptors in the rat dorsolateral prostate, Prostate, 37, 36, 10.1002/(SICI)1097-0045(19980915)37:1<36::AID-PROS6>3.0.CO;2-6 Chang, 2000, Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats, J. Nutr, 130, 1963, 10.1093/jn/130.8.1963 Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc. Natl. Acad. Sci. U.S.A, 90, 2690, 10.1073/pnas.90.7.2690 Fotsis, 1997, Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, 57, 2916 Fajardo, 2000, Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells, Anticancer Res, 20, 1691 Zhou, 1999, Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice, J. Nutr, 129, 1628, 10.1093/jn/129.9.1628 Li, 1999, Soybean isoflavones reduce experimental metastasis in mice, J. Nutr, 129, 1075, 10.1093/jn/129.5.1075 Iishi, 2000, Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in wistar rats, Int. J. Cancer, 86, 416, 10.1002/(SICI)1097-0215(20000501)86:3<416::AID-IJC17>3.0.CO;2-# Yan, 1997, Effect of dietary supplementation of soybeans on experimental metastasis of melanoma cells in mice, Nutr. Cancer, 29, 1, 10.1080/01635589709514594 Menon, 1998, Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells, Nutr. Cancer, 30, 74, 10.1080/01635589809514644 Hakkak, 2000, Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats, Cancer Epidemiol. Biomark. Prev, 9, 113 Gotoh, 1998, Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A, Jpn. J. Cancer Res, 89, 137, 10.1111/j.1349-7006.1998.tb00541.x Hawrylewicz, 1991, Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats, J. Nutr, 121, 1693, 10.1093/jn/121.10.1693 Baggott, 1990, Effect of miso (Japanese soybean paste) and NaCl on DMBA-induced rat mammary tumors, Nutr. Cancer, 14, 103, 10.1080/01635589009514083 Ohta, 2000, Inhibitory effects of bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones, Carcinogenesis, 21, 937, 10.1093/carcin/21.5.937 Cohen, 2000, Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis, Carcinogenesis, 21, 929, 10.1093/carcin/21.5.929 Carroll, 1975, Experimental evidence of dietary factors and hormone-dependent cancers, Cancer Res, 35, 3374 Gridley, 1983, Modification of spontaneous mammary tumors in mice fed different sources of protein, fat and carbohydrate, Cancer Lett, 19, 133, 10.1016/0304-3835(83)90147-7 Hsueh, A. M., Shipley, R. & Park, H. S. (1992) Quality of dietary protein during initiation and promotion of chemical carcinogenesis in rats. In:Dietary Proteins. How They Alleviate Disease and Promote Better Health (Liepa, G.U., ed.). American Oil Chemists’ Society, Champaign, IL. Gotoh, 1998, Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination, Jpn. J. Cancer Res, 89, 487, 10.1111/j.1349-7006.1998.tb03288.x Barnes, 1994, Potential role of dietary isoflavones in the prevention of cancer, Adv. Exp. Med. Biol, 354, 135, 10.1007/978-1-4899-0939-8_10 Zaizen, 2000, Antitumor effects of soybean hypocotyls and soybeans on the mammary tumor induction by N-methyl-N-nitrosourea in F344 rats, Anticancer Res, 20, 1439 Constantinou, 1996, Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones, Anticancer Res, 16, 3293 Murillo, 1998, The antitumorigenic properties of ipriflavone and genistin in rat mammary tissues, FASEB J, 12, A828 Tsukamoto, 1995, Factors affecting isoflavone content in soybean seeds: changes in isoflavones, saponins, and composition of fatty acids at different temperatures during seed development, J. Agric. Food Chem, 43, 1184, 10.1021/jf00053a012 Brown, 2001, Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones, Lab. Investig, 81, 735, 10.1038/labinvest.3780282 Lampe, 2001, Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women, J. Nutr, 131, 740, 10.1093/jn/131.3.740 Rowland, 2000, Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora, Nutr. Cancer, 36, 27, 10.1207/S15327914NC3601_5 Duncan, 2000, Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer, Cancer Epidemiol. Biomark. Prev, 9, 581 Setchell, 1984, Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease, Am. J. Clin. Nutr, 40, 569, 10.1093/ajcn/40.3.569 Hodgson, 1999, Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomized controlled trial, Am. J. Hypertens, 12, 47, 10.1016/S0895-7061(98)00216-7 Peterson, 1996, The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A, Carcinogenesis, 17, 1861, 10.1093/carcin/17.9.1861 Day, J. K., Besch-Williford, C., McMann, T. R., Hufford, M. G., Lubahn, D. B. & MacDonald, R. S. (2001) Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type but not ERa KO mice. Nutr. Cancer (in press). Hawrylewicz, 1995, Soy and experimental cancer: animal studies, J. Nutr, 125, 698S Lu, 2000, Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells, Nutr. Cancer, 38, 123, 10.1207/S15327914NC381_17 Nagata, 2000, Ecological study of the association between soy protein intake and mortality from cancer and heart disease in Japan, Int. J. Epidemiol, 29, 832, 10.1093/ije/29.5.832 Charland, 1998, The effects of a soybean extract on tumor growth and metastasis, Int. J. Mol. Med, 2, 225 Allred, 2001, Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner, Cancer Res, 61, 5045 Makela, 1995, Dietary soybean may be antiestrogenic in male mice, J. Nutr, 125, 437 Seibert, 1983, Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice, Cancer Res, 43, 2223 Trevoux, 1986, Endometrium and plasma hormone profile in the peri-menopause and post-menopause, Maturitas, 8, 309, 10.1016/0378-5122(86)90039-3 Zhu, 1998, Functional role of estrogen metabolism in target cells: review and perspectives, Carcinogenesis, 19, 1, 10.1093/carcin/19.1.1 Szymczak, 1998, Concentration of sex steroids in adipose tissue after menopause, Steroids, 63, 319, 10.1016/S0039-128X(98)00019-1 Lamartiniere, 2000, Protection against breast cancer with genistein: a component of soy, Am. J. Clin. Nutr. discussion 1708S–1709S, 71, 1705S, 10.1093/ajcn/71.6.1705S Lamartiniere, 1995, Neonatal genistein chemoprevents mammary cancer, Proc. Soc. Exp. Biol. Med, 208, 120, 10.3181/00379727-208-43843 Lamartiniere, 1995, Genistein suppresses mammary cancer in rats, Carcinogenesis, 16, 2833, 10.1093/carcin/16.11.2833 Murrill, 1996, Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats, Carcinogenesis, 17, 1451, 10.1093/carcin/17.7.1451 Fritz, 1998, Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat, Carcinogenesis, 19, 2151, 10.1093/carcin/19.12.2151 Hilakivi-Clarke, 1999, Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis, Br. J. Cancer, 80, 1682, 10.1038/sj.bjc.6690584 Russo, 1978, DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis, J. Natl. Cancer Inst, 61, 1451 Grubbs, 1985, Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone, J. Natl. Cancer Inst, 74, 927 Russo, 1979, Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion, Am. J. Pathol, 96, 721 Guzman, 1999, Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy, Proc. Natl. Acad. Sci. U.S.A, 96, 2520, 10.1073/pnas.96.5.2520 MacMahon, 1970, Age at first birth and breast cancer risk, Bull. WHO, 43, 209 Hilakivi-Clarke, 1998, Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring, Oncol. Rep, 5, 609 Hilakivi-Clarke, 2001, Maternal and prepubertal diet, mammary development and breast cancer risk, J. Nutr, 131, 154S, 10.1093/jn/131.1.154S Hilakivi-Clarke, 1999, Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring, Oncol. Rep, 6, 1089 Morrison, 1976, Some international differences in treatment and survival in breast cancer, Int. J. Cancer, 18, 269, 10.1002/ijc.2910180302 Hutchins, 1995, Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products, J. Am. Diet. Assoc, 95, 545, 10.1016/S0002-8223(95)00149-2 Meng, 1997, Ethnic differences and factors related to breast cancer survival in Hawaii, Int. J. Epidemiol, 26, 1151, 10.1093/ije/26.6.1151 Yonemoto, 1980, Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival, Arch. Surg, 115, 1056, 10.1001/archsurg.1980.01380090036009 Huang, 2000, Effects of dietary, drinking, and smoking habits on the prognosis of gastric cancer, Nutr. Cancer, 38, 30, 10.1207/S15327914NC381_5 Pisani, 1999, Estimates of the worldwide mortality from 25 cancers in 1990, Int. J. Cancer, 83, 18, 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M Trock, 2000, Meta-analysis of soy intake and breast cancer risk, J. Nutr, 130, 690S Yuan, 1995, Diet and breast cancer in Shanghai and Tianjin, China, Br. J. Cancer, 71, 1353, 10.1038/bjc.1995.263 Hirohata, 1985, Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan, Natl. Cancer Inst. Monogr, 69, 187 Nomura, 1978, Breast cancer and diet among the Japanese in Hawaii, Am. J. Clin. Nutr, 31, 2020, 10.1093/ajcn/31.11.2020 Key, 1999, Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan, Br. J. Cancer, 81, 1248, 10.1038/sj.bjc.6690837 Hirose, 1995, A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status, Jpn. J. Cancer Res, 86, 146, 10.1111/j.1349-7006.1995.tb03032.x Chie, 1997, Soybean products, vegetable and fruit and breast cancer risk in Taiwan, Breast Cancer Res. Treat, 46, 80 Wu, 1996, Tofu and risk of breast cancer in Asian-Americans, Cancer Epidemiol. Biomark. Prev, 5, 901 Kudo, 2000, Evolution of meal patterns and food choices of Japanese-American females born in the United States, Eur. J. Clin. Nutr, 54, 665, 10.1038/sj.ejcn.1601072 Horn-Ross, 2000, Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States), Cancer Causes Control, 11, 289, 10.1023/A:1008995606699 Huang, 2000, Nutrient intakes in an ethnically diverse sample of US women, Am. J. Epidemiol, 151, S62 Wu, 1998, Soy intake and risk of breast cancer in Asians and Asian Americans, Am. J. Clin. Nutr, 68, 1437S, 10.1093/ajcn/68.6.1437S Ingram, 1997, Case-control study of phyto-oestrogens and breast cancer, Lancet, 350, 990, 10.1016/S0140-6736(97)01339-1 Murkies, 2000, Phytoestrogens and breast cancer in postmenopausal women: a case control study, Menopause, 7, 289, 10.1097/00042192-200007050-00003 Greenstein, 1996, Risk of breast cancer associated with intake of specific foods and food groups, Am. J. Epidemiol, 11, S36 Shu, 2001, Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women, Cancer Epidemiol. Biomark. Prev, 10, 483 Shimizu, 1991, Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county, Br. J. Cancer, 63, 963, 10.1038/bjc.1991.210 Nagata, 1998, Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women, J. Natl. Cancer Inst, 90, 1830, 10.1093/jnci/90.23.1830 Lu, 1996, Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction, Cancer Epidemiol. Biomark. Prev, 5, 63 Brzezinski, 1997, Short-term effect of phytoestrogen-rich diet on postmenopausal women, Menopause, 4, 89, 10.1097/00042192-199704020-00005 Petrakis, 1996, Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women, Cancer Epidemiol. Biomark. Prev, 5, 785 Cassidy, 1995, Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products, Br. J. Nutr, 74, 587, 10.1079/BJN19950160 Baird, 1995, Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women, J. Clin. Endocrinol. Metab, 80, 1685 Martini, 1999, Effects of soy intake on sex hormone metabolism in premenopausal women, Nutr. Cancer, 34, 133, 10.1207/S15327914NC3402_2 Wu, 2000, Effects of soy foods on ovarian function in premenopausal women, Br. J. Cancer, 82, 1879, 10.1054/bjoc.1999.1218 Duncan, 1999, Modest hormonal effects of soy isoflavones in postmenopausal women, J. Clin. Endocrinol. Metab, 84, 3479 Xu, 2000, Soy consumption alters endogenous estrogen metabolism in postmenopausal women, Cancer Epidemiol. Biomark. Prev, 9, 781 Lu, 2000, Increased urinary excretion of 2-hydroxyestrone but not 16α-hydroxyestrone in premenopausal women during a soya diet containing isoflavones, Cancer Res, 60, 1299 Riza, 2001, Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women, Cancer Epidemiol. Biomark. Prev, 10, 627 Loukovaara, 1995, Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HEP G2 cell cultures, Steroids, 60, 656, 10.1016/0039-128X(95)00089-9 Adlercreutz, 1992, Dietary phytoestrogens and cancer: in vitro and in vivo studies, J. Steroid Biochem. Mol. Biol, 41, 331, 10.1016/0960-0760(92)90359-Q Pino, 2000, Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women, J. Clin. Endocrinol. Metab, 85, 2797 Knight, 2001, Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation, Climacteric, 4, 13, 10.1080/cmt.4.1.13.18 Xu, 1998, Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women, Cancer Epidemiol. Biomark. Prev, 7, 1101 Habito, 2000, Effects of replacing meat with soyabean in the diet on sex hormone concentrations in healthy adult males, Br. J. Nutr, 84, 557, 10.1017/S0007114500001872 Mackey, 2000, The effects of soy protein in women and men with elevated plasma lipids, Biofactors, 12, 251, 10.1002/biof.5520120138 Cassidy, 1994, Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women [see comments], Am. J. Clin. Nutr, 60, 333, 10.1093/ajcn/60.3.333 Lu, 2000, Decreased ovarian hormones during a soya diet: implications for breast cancer prevention, Cancer Res, 60, 4112 Petrakis, 1993, Nipple aspirate fluid in epidemiologic studies of breast disease, Epidemiol. Rev, 15, 188, 10.1093/oxfordjournals.epirev.a036104 Wrensch, 1992, Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid, Am. J. Epidemiol, 135, 130, 10.1093/oxfordjournals.aje.a116266 Wrensch, 1993, Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy, Am. J. Epidemiol, 137, 829, 10.1093/oxfordjournals.aje.a116744 Petrakis, 1998, Birthplace and yield of nipple aspirate fluid in Chinese women, Cancer Epidemiol. Biomark. Prev, 7, 835 Hargreaves, 1999, Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast, J. Clin. Endocrinol. Metab, 84, 4017 Preston-Martin, 1990, Increased cell division as a cause of human cancer, Cancer Res, 50, 7415 Preston-Martin, 1993, Epidemiologic evidence for the increased cell proliferation model of carcinogenesis, Environ. Health Perspect, 101, 137 Mommers, 1999, Balance of cell proliferation and apoptosis in breast carcinogenesis, Breast Cancer Res. Treat, 58, 163, 10.1023/A:1006396103777 Messina, 1999, Soy, soy phytoestrogens (isoflavones), and breast cancer [letter], Am. J. Clin. Nutr, 70, 574, 10.1093/ajcn/70.4.574 McMichael-Phillips, 1998, Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast, Am. J. Clin. Nutr, 68, 1431S, 10.1093/ajcn/68.6.1431S Vachon, 2000, Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States), Cancer Causes Control, 11, 653, 10.1023/A:1008926607428 Boyd, 2001, Mammographic density as a marker of susceptibility to breast cancer: a hypothesis, IARC Sci. Publ, 154, 163 Boyd, 2001, Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention, Curr. Oncol. Rep, 3, 314, 10.1007/s11912-001-0083-7 Laya, 1995, Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern, Radiology, 196, 433, 10.1148/radiology.196.2.7617857 Colditz, 1998, Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer, J. Natl. Cancer Inst, 90, 814, 10.1093/jnci/90.11.814 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer, Lancet, 350, 1047, 10.1016/S0140-6736(97)08233-0 Thomas, 1997, Endogenous estrogen and postmenopausal breast cancer: a quantitative review, Cancer Causes Control, 8, 922, 10.1023/A:1018476631561 Morabia, 1998, International variability in ages at menarche, first livebirth, and menopause. World Health Organization collaborative study of neoplasia and steroid contraceptives [published erratum appears in Am. J. Epidemiol. 150: 546], Am. J. Epidemiol, 148, 1195, 10.1093/oxfordjournals.aje.a009609 Buist, 2001, Bone mineral density and breast cancer risk in postmenopausal women, J. Clin. Epidemiol, 54, 417, 10.1016/S0895-4356(00)00301-2 Zhang, 1997, Bone mass and the risk of breast cancer among postmenopausal women, N. Engl. J. Med, 336, 611, 10.1056/NEJM199702273360903 Lucas, 1998, Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of osteoporotic fractures research group, Am. J. Epidemiol, 148, 22, 10.1093/oxfordjournals.aje.a009554 Nguyen, 2000, Association between breast cancer and bone mineral density: the Dubbo osteoporosis epidemiology study, Maturitas, 36, 27, 10.1016/S0378-5122(00)00133-X Zmuda, 2001, Bone mass and breast cancer risk in older women: differences by stage at diagnosis, J. Natl. Cancer Inst, 93, 930, 10.1093/jnci/93.12.930 Newman, 1997, The effect of body mass index and oestrogen receptor level on survival of breast cancer patients, Int. J. Epidemiol, 26, 484, 10.1093/ije/26.3.484 Bastarrachea, 1994, Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer, Ann. Intern. Med, 120, 18, 10.7326/0003-4819-120-1-199401010-00004 Proceedings of a conference held at Boar’s Head Inn Charlottesville Virginia September 21–23 (1999) Treatment of oestrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Oncology 13: 859–875. Loprinzi, 2000, Estrogen deficiency: in search of symptom control and sexuality, J. Natl. Cancer Inst, 92, 1028, 10.1093/jnci/92.13.1028 Vassilopoulou-Sellin, 1999, Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively, J. Clin. Oncol, 17, 1482, 10.1200/JCO.1999.17.5.1482 Gapstur, 1999, Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study, J. Am. Med. Assoc, 281, 2091, 10.1001/jama.281.22.2091 Cobleigh, 1999, Hormone replacement therapy and high S phase in breast cancer, J. Am. Med. Assoc, 281, 1528, 10.1001/jama.281.16.1528 Manjer, 2001, Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy, Int. J. Cancer, 92, 919, 10.1002/ijc.1279 Delgado, 2001, Prognosis of breast cancers detected in women receiving hormone replacement therapy, Maturitas, 38, 147, 10.1016/S0378-5122(00)00213-9 O'Meara, 2001, Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality, J. Natl. Cancer Inst, 93, 754, 10.1093/jnci/93.10.754 Schairer, 2000, Estrogen-progestin replacement and risk of breast cancer, J. Am. Med. Assoc, 284, 691 Schairer, 2000, Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk, J. Am. Med. Assoc, 283, 485, 10.1001/jama.283.4.485 Pike, 2000, Response: Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin, J. Natl. Cancer Inst, 92, 1951, 10.1093/jnci/92.23.1951 Ross, 2000, Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin, J. Natl. Cancer Inst, 92, 328, 10.1093/jnci/92.4.328 Santen, 2001, Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy, J. Clin. Endocrinol. Metab, 86, 16, 10.1210/jcem.86.1.7269 Persson, 1999, Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement, Cancer Causes Control, 10, 253, 10.1023/A:1008909128110 Pike, 1993, Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk, Epidemiol. Rev, 15, 17, 10.1093/oxfordjournals.epirev.a036102 Soderqvist, 1997, Proliferation of breast epithelial cells in healthy women during the menstrual cycle, Am. J. Obstet. Gynecol, 176, 123, 10.1016/S0002-9378(97)80024-5 Hofseth, 1999, Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast, J. Clin. Endocrinol. Metab, 84, 4559 Cline, 1996, Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques, Am. J. Obstet. Gynecol, 174, 93, 10.1016/S0002-9378(96)70379-4 Conner, 2001, Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology, Climacteric, 4, 7, 10.1080/cmt.4.1.7.12 Lundstrom, 1999, Mammographic breast density during hormone replacement therapy: differences according to treatment, Am. J. Obstet. Gynecol, 181, 348, 10.1016/S0002-9378(99)70560-0 Greendale, 1999, Effects of estrogen and estrogen-progestin on mammographic parenchymal density, Postmenopausal estrogen/progestin interventions (PEPI) investigators. Ann. Intern. Med, 130, 262 Lundstrom, 2001, Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens, Climacteric, 4, 42, 10.1080/cmt.4.1.42.48 Jasieriska, 2001, Lifestyle, hormones, and risk of breast cancer, Br. Med. J, 322, 586, 10.1136/bmj.322.7286.586 Zava, 1998, Estrogen and progestin bioactivity of foods, herbs, and spices, Proc. Soc. Exp. Biol. Med, 217, 369, 10.3181/00379727-217-44247 Schwartz, 1998, Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes, Biochem. Biophys. Res. Commun, 253, 38, 10.1006/bbrc.1998.9751 Sugimoto, 2000, Anabolic effect of genistein in osteoblastic MC3T3–E1 cells, Int. J. Mol. Med, 5, 515 Sugimoto, 2000, Stimulatory effect of daidzein in osteoblastic MC3T3–E1 cells, Biochem. Pharmacol, 59, 471, 10.1016/S0006-2952(99)00351-2 Choi, 2001, Soybean ethanol extract increases the function of osteoblastic MC3T3–E1 cells, Phytochemistry, 56, 733, 10.1016/S0031-9422(00)00484-2 Constantinou, 2001, Consumption of soy products may enhance tamoxifen's breast cancer preventive effects, Proc. Am. Assoc. Cancer Res, 42, 826 Schardt, 2000, Phytoestrogens for menopause, Nutrition Action HealthLetter, 27, 8 2000, The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society, Menopause, 7, 215, 10.1097/00042192-200007040-00003 Potter, 1998, Soy protein and cardiovascular disease: the impact of bioactive components in soy, Nutr. Rev, 56, 231, 10.1111/j.1753-4887.1998.tb01754.x Crouse, 1999, A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins, Arch. Intern. Med, 159, 2070, 10.1001/archinte.159.17.2070 Urban, 2001, The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen, J. Urol, 165, 294, 10.1097/00005392-200101000-00082